American Well Corporation reported its first‑quarter 2026 financial results, posting revenue of $54.88 million and an earnings per share of $‑0.66. Both figures surpassed consensus estimates of $51.54 million and $‑0.77, respectively, giving the company a modest earnings beat of $0.11 per share.
Revenue fell 18% year‑over‑year, but the decline was offset by growth in key high‑margin segments. Amwell Medical Group visit revenue increased 9% YoY, while Virtual Primary Care visits surged 57% YoY, underscoring momentum in the company’s core service lines.
Gross margin for the quarter was 51%, a slight compression from 53% in the same period a year earlier. Despite the margin squeeze, the company’s earnings beat was largely driven by disciplined cost control and improved operating leverage, which helped offset the revenue decline and maintain profitability.
Management reaffirmed its full‑year 2026 revenue guidance of $195–$205 million and updated its adjusted EBITDA guidance to a loss of $16–$12 million, an improvement over the prior range. The guidance signals confidence in the company’s ability to continue narrowing losses while pursuing growth.
The results reflect a mixed picture: revenue contraction and margin compression highlight ongoing headwinds, yet growth in high‑margin segments, a focus on cost reduction, and strategic investments in AI and government contracts position Amwell for a more profitable future. The company’s emphasis on profitability and operational efficiency remains a central theme in its outlook.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.